Appointments Jobs About Search Education & Research Clinical Trials Health Information Medical Services

Publications - Eduardo E . Benarroch, M.D.

Back to Research Profile

  1. Benarroch EE. The locus ceruleus norepinephrine system: functional organization and potential clinical significance. Neurology 2009 Nov 17; 73(20):1699-704.
    View PubMed
  2. Benarroch EE. Astrocyte-neuron interactions: implications for epilepsy. Neurology 2009 Oct 20; 73(16):1323-7.
    View PubMed
  3. Cersosimo MG, Tumilasci OR, Raina GB, Benarroch EE, Cardoso EM, Micheli F, Pazo JH. Hyposialorrhea as an early manifestation of Parkinson disease. Auton Neurosci 2009 Oct 5; 150(1-2):150-1.
    View PubMed
  4. Benarroch EE. Serotonergic modulation of basal ganglia circuits: complexity and therapeutic opportunities. Neurology 2009 Sep 15; 73(11):880-6.
    View PubMed
  5. Benarroch EE. Hypoxia-induced mediators and neurologic disease. Neurology 2009 Aug 18; 73(7):560-5.
    View PubMed
  6. Cersosimo MG, Raina GB, Benarroch EE, Piedimonte F, Aleman GG, Micheli FE. Micro lesion effect of the globus pallidus internus and outcome with deep brain stimulation in patients with Parkinson disease and dystonia. Mov Disord 2009 Jul 30; 24(10):1488-93.
    View PubMed
  7. Benarroch EE. Autonomic-mediated immunomodulation and potential clinical relevance. Neurology 2009 Jul 21; 73(3):236-42.
    View PubMed
  8. Benarroch EE. Oligodendrocytes: Susceptibility to injury and involvement in neurologic disease. Neurology 2009 May 19; 72(20):1779-85.
    View PubMed
  9. Benarroch EE. Brain iron homeostasis and neurodegenerative disease. Neurology 2009 Apr 21; 72(16):1436-40.
    View PubMed
  10. Benarroch EE. Neuropeptide Y: its multiple effects in the CNS and potential clinical significance. Neurology 2009 Mar 17; 72(11):1016-20.
    View PubMed
  11. Benarroch EE. Potassium channels: brief overview and implications in epilepsy. Neurology 2009 Feb 17; 72(7):664-9.
    View PubMed
  12. Benarroch EE. Gamma-hydroxybutyric acid and its relevance in neurology. Neurology 2009 Jan 20; 72(3):282-6.
    View PubMed
  13. Idiaquez J, Araya P, Benarroch E. Orthostatic hypotension associated with dorsal medullary cavernous angioma. Acta Neurol Scand 2009 Jan; 119(1):45-8.
    View PubMed
  14. Benarroch EE. The arterial baroreflex: functional organization and involvement in neurologic disease. Neurology 2008 Nov 18; 71(21):1733-8.
    View PubMed
  15. Benarroch EE. Brain cholesterol metabolism and neurologic disease. Neurology 2008 Oct 21; 71(17):1368-73.
    View PubMed
  16. Vogel ER, Corfits JL, Sandroni P, Sletten DM, Benarroch EE, Fealey RD, Suarez GA, Gehrking TL, Gehrking JA, Low PA. Effect of position on valsalva maneuver: supine versus 20 degree position. J Clin Neurophysiol 2008 Oct; 25(5):313-6.
    View PubMed
  17. Benarroch EE. The midline and intralaminar thalamic nuclei: anatomic and functional specificity and implications in neurologic disease. Neurology 2008 Sep 16; 71(12):944-9.
    View PubMed
  18. Dhamija R, Tan KM, Pittock SJ, Foxx-Orenstein A, Benarroch E, Lennon VA. Serologic profiles aiding the diagnosis of autoimmune gastrointestinal dysmotility. Clin Gastroenterol Hepatol 2008 Sep; 6(9):988-92. Epub 2008 Jul 02.
    View PubMed
  19. Benarroch EE. Suprachiasmatic nucleus and melatonin: reciprocal interactions and clinical correlations. Neurology 2008 Aug 19; 71(8):594-8.
    View PubMed
  20. Benarroch EE. Descending monoaminergic pain modulation: bidirectional control and clinical relevance. Neurology 2008 Jul 15; 71(3):217-21.
    View PubMed
  21. Cersosimo MG, Benarroch EE. Neural control of the gastrointestinal tract: implications for Parkinson disease. Mov Disord 2008 Jun 15; 23(8):1065-75.
    View PubMed
  22. Benarroch EE, Schmeichel AM, Low PA, Sandroni P, Parisi JE. Loss of A5 noradrenergic neurons in multiple system atrophy. Acta Neuropathol 2008 Jun; 115(6):629-34. Epub 2008 Feb 23.
    View PubMed
  23. Benarroch EE. Subthalamic nucleus and its connections: Anatomic substrate for the network effects of deep brain stimulation. Neurology 2008 May 20; 70(21):1991-5.
    View PubMed
  24. Benarroch EE. N-acetylaspartate and N-acetylaspartylglutamate: neurobiology and clinical significance. Neurology 2008 Apr 15; 70(16):1353-7.
    View PubMed
  25. Benarroch EE. Metabotropic glutamate receptors: synaptic modulators and therapeutic targets for neurologic disease. Neurology 2008 Mar 18; 70(12):964-8.
    View PubMed
  26. Rabinstein AA, Benarroch EE. Treatment of paroxysmal sympathetic hyperactivity. Curr Treat Options Neurol 2008 Mar; 10(2):151-7.
    View PubMed
  27. Rabinstein AA, Benarroch EE. Treatment of paroxysmal sympathetic hyperactivity. Curr Treat Options Neurol 2008 Mar; 10(2):151-7.
    View PubMed
  28. Benarroch EE. TRP channels: functions and involvement in neurologic disease. Neurology 2008 Feb 19; 70(8):648-52.
    View PubMed
  29. Tsuboi Y, Dickson DW, Nabeshima K, Schmeichel AM, Wszolek ZK, Yamada T, Benarroch EE. Neurodegeneration involving putative respiratory neurons in Perry syndrome. Acta Neuropathol 2008 Feb; 115(2):263-8. Epub 2007 Jun 19.
    View PubMed
  30. Schmeichel AM, Buchhalter LC, Low PA, Parisi JE, Boeve BW, Sandroni P, Benarroch EE. Mesopontine cholinergic neuron involvement in Lewy body dementia and multiple system atrophy. Neurology 2008 Jan 29; 70(5):368-73.
    View PubMed
  31. Benarroch EE. Adenosine and its receptors: multiple modulatory functions and potential therapeutic targets for neurologic disease. Neurology 2008 Jan 15; 70(3):231-6.
    View PubMed
  32. Benarroch EE. Aquaporin-4, homeostasis, and neurologic disease. Neurology 2007 Dec 11; 69(24):2266-8.
    View PubMed
  33. Benarroch EE. Enteric nervous system: functional organization and neurologic implications. Neurology 2007 Nov 13; 69(20):1953-7.
    View PubMed
  34. Boeve BF, Silber MH, Saper CB, Ferman TJ, Dickson DW, Parisi JE, Benarroch EE, Ahlskog JE, Smith GE, Caselli RC, Tippman-Peikert M, Olson EJ, Lin SC, Young T, Wszolek Z, Schenck CH, Mahowald MW, Castillo PR, Del Tredici K, Braak H. Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. Brain 2007 Nov; 130(Pt 11):2770-88. Epub 2007 Apr 05.
    View PubMed
  35. Benarroch EE. Lipid rafts, protein scaffolds, and neurologic disease. Neurology 2007 Oct 16; 69(16):1635-9.
    View PubMed
  36. Benarroch EE. Thermoregulation: recent concepts and remaining questions. Neurology 2007 Sep 18; 69(12):1293-7.
    View PubMed
  37. Drubach D, Benarroch EE, Mateen FJ. [Imagination: its definition, purposes and neurobiology]. Rev Neurol 2007 Sep 16-30; 45(6):353-8.
    View PubMed
  38. Benarroch EE, Schmeichel AM, Sandroni P, Parisi JE, Low PA. Rostral raphe involvement in Lewy body dementia and multiple system atrophy. Acta Neuropathol 2007 Sep; 114(3):213-20. Epub 2007 Jul 17.
    View PubMed
  39. Benarroch EE. Tissue plasminogen activator: beyond thrombolysis. Neurology 2007 Aug 21; 69(8):799-802.
    View PubMed
  40. Ghearing GR, Munger TM, Jaffe AS, Benarroch EE, Britton JW. Clinical cues for detecting ictal asystole. Clin Auton Res 2007 Aug; 17(4):221-6. Epub 2007 Jul 16.
    View PubMed
  41. Spinner RJ, Amrami KK, Wolanskyj AP, Desy NM, Wang H, Benarroch EE, Skinner JA, Rock MG, Scheithauer BW. Dynamic phases of peroneal and tibial intraneural ganglia formation: a new dimension added to the unifying articular theory. J Neurosurg 2007 Aug; 107(2):296-307.
    View PubMed
  42. Benarroch E. Endocannabinoids in basal ganglia circuits: implications for Parkinson disease. Neurology 2007 Jul 17; 69(3):306-9.
    View PubMed
  43. Benarroch EE. Brainstem respiratory chemosensitivity: new insights and clinical implications. Neurology 2007 Jun 12; 68(24):2140-3.
    View PubMed
  44. Roemer SF, Parisi JE, Lennon VA, Benarroch EE, Lassmann H, Bruck W, Mandler RN, Weinshenker BG, Pittock SJ, Wingerchuk DM, Lucchinetti CF. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain 2007 May; 130(Pt 5):1194-205.
    View PubMed
  45. Benarroch EE. Rho GTPases: role in dendrite and axonal growth, mental retardation, and axonal regeneration. Neurology 2007 Apr 17; 68(16):1315-8.
    View PubMed
  46. Idiaquez J, Benarroch EE, Rosales H, Milla P, Rios L. Autonomic and Cognitive dysfunction in Parkinson's disease. Clin Auton Res 2007 Apr; 17(2):93-8.
    View PubMed
  47. Benarroch EE. Neurosteroids: endogenous modulators of neuronal excitability and plasticity. Neurology 2007 Mar 20; 68(12):945-7.
    View PubMed
  48. Whitwell JL, Weigand SD, Shiung MM, Boeve BF, Ferman TJ, Smith GE, Knopman DS, Petersen RC, Benarroch EE, Josephs KA, Jack CR Jr. Focal atrophy in dementia with Lewy bodies on MRI: a distinct pattern from Alzheimer's disease. Brain 2007 Mar; 130(Pt 3):708-19. Epub 2007 Jan 31.
    View PubMed
  49. Benarroch EE. GABAA receptor heterogeneity, function, and implications for epilepsy. Neurology 2007 Feb 20; 68(8):612-4.
    View PubMed
  50. Benarroch EE, Schmeichel AM, Low PA, Parisi JE. Depletion of putative chemosensitive respiratory neurons in the ventral medullary surface in multiple system atrophy. Brain 2007 Feb; 130(Pt 2):469-75.
    View PubMed
  51. Benarroch EE. Sodium channels and pain. Neurology 2007 Jan 16; 68(3):233-6.
    View PubMed
  52. Benarroch EE. Brainstem respiratory control: substrates of respiratory failure of multiple system atrophy. Mov Disord 2007 Jan 15; 22(2):155-61.
    View PubMed
  53. Boeve BF, Dickson DW, Olson EJ, Shepard JW, Silber MH, Ferman TJ, Ahlskog JE, Benarroch EE. Insights into REM sleep behavior disorder pathophysiology in brainstem-predominant Lewy body disease. Sleep Med 2007 Jan; 8(1):60-4. Epub 2006 Dec 06.
    View PubMed
  54. Benarroch EE, Schmeichel AM, Sandroni P, Low PA, Parisi JE. Involvement of hypocretin neurons in multiple system atrophy. Acta Neuropathol 2007 Jan; 113(1):75-80. Epub 2006 Nov 07.
    View PubMed
  55. Benarroch EE, Schmeichel AM, Sandroni P, Low PA, Parisi JE. Differential involvement of hypothalamic vasopressin neurons in multiple system atrophy. Brain 2006 Oct; 129(Pt 10):2688-96. Epub 2006 May 02.
    View PubMed
  56. Pittock SJ, Yoshikawa H, Ahlskog JE, Tisch SH, Benarroch EE, Kryzer TJ, Lennon VA. Glutamic acid decarboxylase autoimmunity with brainstem, extrapyramidal, and spinal cord dysfunction. Mayo Clin Proc 2006 Sep; 81(9):1207-14.
    View PubMed
  57. Rodriguez AJ, Jicha GA, Steeves TD, Benarroch EE, Westmoreland BF. EEG changes in a patient with steroid-responsive encephalopathy associated with antibodies to thyroperoxidase (SREAT, Hashimoto's encephalopathy). J Clin Neurophysiol 2006 Aug; 23(4):371-3.
    View PubMed
  58. Cheshire WP, Dickson DW, Nahm KF, Kaufmann HC, Benarroch EE. Dopamine β-hydroxylase deficiency involves the central autonomic network. Acta Neuropathol (Berl) 2006 Aug; 112(2):227-9.
    View PubMed
  59. Tumilasci OR, Cersosimo MG, Belforte JE, Micheli FE, Benarroch EE, Pazo JH. Quantitative study of salivary secretion in Parkinson's disease. Mov Disord 2006 May; 21(5):660-7.
    View PubMed
  60. Benarroch EE. Pain-autonomic interactions. Neurol Sci 2006 May; 27 Suppl 2:S130-3.
    View PubMed
  61. Britton JW, Ghearing GR, Benarroch EE, Cascino GD. The ictal bradycardia syndrome: localization and lateralization. Epilepsia 2006 Apr; 47(4):737-44.
    View PubMed
  62. Benarroch EE, Schmeichel AM, Sandroni P, Low PA, Parisi JE. Involvement of vagal autonomic nuclei in multiple system atrophy and Lewy body disease. Neurology 2006 Feb 14; 66(3):378-83.
    View PubMed
  63. Britton JW, Benarroch E. Seizures and syncope: anatomic basis and diagnostic considerations. Clin Auton Res 2006 Feb; 16(1):18-28.
    View PubMed
  64. Benarroch EE. Neuron-astrocyte interactions: Partnership for normal function and disease in the central nervous system. Mayo Clin Proc 2005 Oct; 80(10):1326-38.
    View PubMed
  65. Benarroch EE. Paraventricular nucleus, stress response, and cardiovascular disease. Clin Auton Res 2005 Aug; 15(4):254-63.
    View PubMed
  66. Pittock SJ, Lucchinetti CF, Parisi JE, Benarroch EE, Mokri B, Stephan CL, Kim KK, Killmann MW, Lennon VA. Amphiphysin autoimmunity: paraneoplastic accompaniments. Ann Neurol 2005 Jul; 58(1):96-107.
    View PubMed
  67. Wingerchuk DM, Benarroch EE, O'Brien PC, Keegan BM, Lucchinetti CF, Noseworthy JH, Weinshenker BG, Rodriguez M. A randomized controlled crossover trial of aspirin for fatigue in multiple sclerosis. Neurology 2005 Apr 12; 64(7):1267-9.
    View PubMed
  68. Benarroch EE, Schmeichel AM, Low PA, Boeve BF, Sandroni P, Parisi JE. Involvement of medullary regions controlling sympathetic output in Lewy body disease. Brain 2005 Feb; 128(Part 2):338-44.
    View PubMed
  69. Benarroch EE. Dolor: Conceptos emergentes en fisiologia Y fisiopatologia. Revista Neurologica Argentina 2005; 30:70-82.
  70. Thaisetthawatkul P, Boeve BF, Benarroch EE, Sandroni P, Ferman TJ, Petersen R, Low PA. Autonomic dysfunction in dementia with Lewy bodies. Neurology 2004 May 25; 62(10):1804-9.
    View PubMed
  71. Benarroch EE, Schmeichel AM, Low PA, Parisi JE. Involvement of medullary serotonergic groups in multiple system atrophy. Ann Neurol 2004 Mar; 55(3):418-22.
    View PubMed
  72. Benarroch EE, Schmeichel AM, Low PA, Parisi JE. Depletion of ventromedullary NK-1 receptor-immunoreactive neurons in multiple system atrophy. Brain 2003 Oct; 126(Part 10):2183-90.
    View PubMed
  73. Benarroch EE. Brainstem in multiple system atrophy: Clinicopathological correlations. Cellular & Molecular Neurobiology 2003 Oct; 23(4-5):519-26.
    View PubMed
  74. Boeve B, Silber MH, Parisi JE, Dickson DW, Ferman TJ, Benarroch EE, Schmeichel AM, Smith GE, Petersen RC, Ahlskog JE, Matsumoto JY, Knopman DS, Schenck CH, Mahowald MW. Synucleinopathy pathology and REM sleep behavior disorder plus dementia or parkinsonism. Neurology 2003 Jul 8; 61(1):40-5.
    View PubMed
  75. Benarroch EE, Schmeichel AM, Parisi JE. Preservation of branchimotor neurons of the nucleus ambiguus in multiple system atrophy. Neurology 2003 Jan 14; 60(1):115-7.
    View PubMed
  76. Heidel KM, Benarroch EE, Gene R, Klein F, Meli R, Saadia D, Nogues MA. Cardiovascular and respiratory consequences of bilateral involvement of the medullary intermediate reticular formation in syringobulbia. Clin Auton Res 2002 Dec; 12(6):450-6.
    View PubMed
  77. Benarroch EE, Schmeichel AM, Parisi JE. Depletion of mesopontine cholinergic and sparing of raphe neurons in multiple system atrophy. Neurology 2002 Sep 24; 59(6):944-6.
    View PubMed
  78. Benarroch EE. New findings on the neuropathology of multiple system atrophy. Auton Neurosci 2002 Feb 28; 96(1):59-62.
    View PubMed
  79. Benarroch EE. Pain-autonomic interactions: a selective review. Clin Auton Res 2001 Dec; 11(6):343-9.
    View PubMed
  80. Benarroch EE, Schmeichel AM. Depletion of corticotrophin-releasing factor neurons in the pontine micturition area in multiple system atrophy. Ann Neurol 2001 Nov; 50(5):640-645.
    View PubMed
  81. Nogues M, Delorme R, Saadia D, Heidel K, Benarroch E. Postural tachycardia syndrome in syringomyelia: response to fludrocortisone and beta-blockers. Clin Auton Res 2001 Aug; 11(4):265-267.
    View PubMed
  82. Benarroch EE, Schmeichel AM, Parisi JE. Depletion of cholinergic neurons of the medullary arcuate nucleus in multiple system atrophy. Auton Neurosci 2001 Mar 23; 87(2-3):293-9.
    View PubMed
  83. Yu Z, Kryzer TJ, Griesmann GE, Kim K, Benarroch EE, Lennon VA. CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity. Ann Neurol 2001 Feb; 49(2):146-54.
    View PubMed
  84. Benarroch EE, Schmeichel AM, Parisi JE. Involvement of the ventrolateral medulla in parkinsonism with autonomic failure. Neurology 2000 Feb 22; 54(4):963-8.
    View PubMed
  85. Nogues M, Gene R, Benarroch E, Leiguarda R, Calderon C, Encabo H. Respiratory disturbances during sleep in syringomyelia and syringobulbia. Neurology 1999 Jun 10; 52(9):1777-83.
    View PubMed
  86. Miller SM, Schmalz PF, Benarroch EE, Szurszewski JH. Leptin receptor immunoreactivity in sympathetic prevertebral ganglion neurons of mouse and rat. Neurosci Lett 1999 Apr 16; 265(2):75-8.
    View PubMed
  87. Benarroch EE, Smithson IL. Intrinsic vasomotor innervation of blood vessels in human ventrolateral medulla. Clin Auton Res 1999 Apr; 9(2):91-5.
    View PubMed
  88. Benarroch EE, Schmeichel AM. Immunohistochemical localization of the angiotensin II type 1 receptor in human hypothalamus and brainstem. Brain Res 1998 Nov 23; 812(1-2):292-6.
    View PubMed
  89. Benarroch EE, Stotz-Potter EH. Dysautonomia in fatal familial insomnia as an indicator of the potential role of the thalamus in autonomic control. Brain Pathol 1998 Jul; 8(3):527-30.
    View PubMed
  90. Stotz-Potter E, Benarroch E. Removal of GABAergic inhibition in the mediodorsal nucleus of the rat thalamus leads to increases in heart rate and blood pressure. Neurosci Lett 1998 May 15; 247(2-3):127-30.
    View PubMed
  91. Boeve BF, Wijdicks EF, Benarroch EE, Schmidt KD. Paroxysmal sympathetic storms ("diencephalic seizures") after severe diffuse axonal head injury. Mayo Clin Proc 1998 Feb; 73(2):148-52.
    View PubMed
  92. Benarroch EE, Smithson IL, Low PA, Parisi JE. Depletion of catecholaminergic neurons of the rostral ventrolateral medulla in multiple systems atrophy with autonomic failure. Ann Neurol 1998 Feb; 43(2):156-63.
    View PubMed
  93. Benarroch EE, Smithson IL. Distribution and relationships of neuropeptide Y and NADPH-diaphorase in human ventrolateral medulla oblongata. J Auton Nerv Syst 1997 Feb 17; 62(3):143-6.
    View PubMed
  94. Benarroch EE, Smithson IL. Neuropeptide Y innervation of nitric oxide-synthesizing sympathetic preganglionic neurons in humans. Clin Auton Res 1997 Feb; 7(1):31-4.
    View PubMed
  95. Benarroch EE. [Orthostatic hypotension: diagnosis and treatment]. Rev Neurol 1997 Jan; 25(137):115-9.
    View PubMed
  96. Benarroch EE. [Syncope: neurological differential diagnosis]. Rev Neurol 1997 Jan; 25(137):100-5.
    View PubMed
  97. Sasaki H, Kihara M, Zollman PJ, Nickander KK, Smithson IL, Schmelzer JD, Willner CL, Benarroch EE, Low PA. Chronic constriction model of rat sciatic nerve: nerve blood flow, morphologic and biochemical alterations. Acta Neuropathol (Berl) 1997 Jan; 93(1):62-70.
    View PubMed
  98. Sandroni P, Opfer-Gehrking TL, Benarroch EE, Shen WK, Low PA. Certain cardiovascular indices predict syncope in the postural tachycardia syndrome. Clin Auton Res 1996 Aug; 6(4):225-31.
    View PubMed
  99. Smithson IL, Benarroch EE. Organization of NADPH-diaphorase-reactive neurons and catecholaminergic fibers in human intermediolateral cell column. Brain Res 1996 Jun 3; 723(1-2):218-22.
    View PubMed
  100. Benarroch EE, Smithson IL, Low PA. Localization and possible interactions of catecholamine-and NADPH-diaphorase neurons in human medullary autonomic regions. Brain Res 1995 Jul 3; 684(2):215-20.
    View PubMed
  101. Low PA, Opfer-Gehrking TL, McPhee BR, Fealey RD, Benarroch EE, Willner CL, Suarez GA, Proper CJ, Felten JA, Huck CA. Prospective evaluation of clinical characteristics of orthostatic hypotension. Mayo Clin Proc 1995 Jul; 70(7):617-22.
    View PubMed
  102. Low PA, Opfer-Gehrking TL, Textor SC, Benarroch EE, Shen WK, Schondorf R, Suarez GA, Rummans TA. Postural tachycardia syndrome (POTS). Neurology 1995 Apr; 45(4 Suppl 5):S19-25.
    View PubMed
  103. Benarroch EE. Neuropeptides in the sympathetic system: presence, plasticity, modulation, and implications. Ann Neurol 1994 Jul; 36(1):6-13.
    View PubMed
  104. Benarroch EE, Zollman PJ, Smithson IL, Schmelzer JD, Low PA. Different reinnervation patterns in the celiac/mesenteric and superior cervical ganglia following guanethidine sympathectomy in adult rats. Brain Res 1994 May 2; 644(2):322-6.
    View PubMed
  105. Low PA, Opfer-Gehrking TL, McPhee BR, Fealey RD, Benarroch EE, Willner CL, Suarez GA, Proper CJ, Felten JA, Huck CA, Corfits JL. Prospective evaluation of clinical characteristics of orthostatic hypotension. Clin Auton Res 1994; 4:205.
  106. Benarroch EE. The central autonomic network: functional organization, dysfunction, and perspective. Mayo Clin Proc 1993 Oct; 68(10):988-1001.
    View PubMed
  107. Benarroch EE, Chang FL. Central autonomic disorders. J Clin Neurophysiol 1993 Jan; 10(1):39-50.
    View PubMed
  108. Benarroch EE, Zollman PJ, Schmelzer JD, Nelson DK, Low PA. Guanethidine sympathectomy increases substance P concentration in the superior sympathetic ganglion of adult rats. Brain Res 1992 Jul 3; 584(1-2):305-8.
    View PubMed
  109. Benarroch EE, Opfer-Gehrking TL, Low PA. Use of the photoplethysmographic technique to analyze the Valsalva maneuver in normal man. Muscle & Nerve 1991 Dec; 14(12):1165-72.
    View PubMed
  110. Sandroni P, Benarroch EE, Low PA. Pharmacological dissection of components of the Valsalva maneuver in adrenergic failure. J Appl Physiol 1991 Oct; 71(4):1563-7.
    View PubMed
  111. Benarroch EE, Low PA. The acetylcholine-induced flare response in evaluation of small fiber dysfunction. Ann Neurol 1991 Jun; 29(6):590-5.
    View PubMed
  112. Benarroch EE, Schmelzer JD, Ward KK, Nelson DK, Low PA. Noradrenergic and neuropeptide Y mechanisms in guanethidine-sympathectomized rats. Am J Physiol 1990 Aug; 259(2 Pt 2):R371-5.
    View PubMed
  113. Benarroch EE, Aimone LD, Yaksh TL. Segmental analysis of neuropeptide concentrations in normal human spinal cord. Neurology 1990 Jan; 40(1):137-44.
    View PubMed
  114. Hormes JT, Benarroch EE, Rodriguez M, Klass DW. Periodic sharp waves in baclofen-induced encephalopathy. Arch Neurol 1988 Jul; 45(7):814-5.
    View PubMed
  115. Benarroch EE, Granata AR, Ruggiero DA, Park DH, Reis DJ. Neurons of C1 area mediate cardiovascular responses initiated from ventral medullary surface. Am J Physiol 1986; 250:R932-45.
    View PubMed
  116. Benarroch EE, Granata AR, Giuliano R, Reis DJ. Neurons of the C1 area of rostral ventrolateral medulla mediate nucleus tractus solitarii hypertension. Hypertension 8 ( 1986; Suppl I):I56-60.
  117. Imaizumi T, Granata AR, Benarroch EE, Sved AF, Reis DJ. Contributions of Arginin vasopressin and the sympathetic nervous system to fulminating hypertension after destruction of nervous of caudal ventrolateral medulla in the rat. J Hypertens 1985; 3:491-501.
    View PubMed
  118. Benarroch EE, Balda MS, Finkielman S, Nahmod VE. Neurogenic hypertension after depletion of norepinephrine in anterior hypothalamus induced by 6-hydroxydopamine administration into the ventral pons: role of serotonin. Neuropharmacology 1983; 22:29-34.
    View PubMed
  119. Benarroch EE, Pirola CJ, Alvarez A, Nahmod VE. Serotonergic and noradrenergic mechanisms involved in the cardiovascular effects of angiotensin II injected into the anterior hypothalamic preoptic region of the rat. Neuropharmacology 1981; 20:9-13.
    View PubMed
  120. Alvarez A, Pirola CJ, Benarroch EE, Finkielman S, Nahmod VE. Muscarinic receptor involvement of electrolytic change of kidney tubular cells elicited by bradykinin and cholinergic agonists. ICRS Med Sci 1980; 8:197.
  121. Benarroch EE, Pirola CJ, Finkielman S, Nahmod VE. Cholinergic mechanisms involved in the pressor action of bradykinin in the lateral septal area of the rat. ICRS Med Sci 1980; 8:83.
  122. Pirola CJ, Criscuolo M, Alvarez A, Benarroch EE, Finkielman S, Nahmod VE. Cholinergic mechanisms involved in the natriuretic effects of Fursemide. ICRS Med Sci 8:214, 1980.
  123. Nahmod VE, Finkielman S, Benarroch EE, Pirola CJ. Angiotensin regulates release and synthesis of serotonin in brain. Science 1978; 202:1091-3.
    View PubMed


Appointments Contact Us Make A Gift Search

Legal restrictions and terms of use applicable to this site

Use of this site signifies your agreement to the terms of use
Copyright © 2009 Mayo Foundation for Medical Education and Research.